True North Therapeutics is a pioneering biotechnology company selectively inhibiting the Complement pathway for diseases of high unmet clinical need. The company’s lead monoclonal antibody, TNT009, targets the Classical Complement pathway, enabling selective inhibition of downstream phagocytosis, inflammation, and cell lysis. True North is currently focused on Complement-mediated rare diseases in the hematologic, renal, and neurological space. True North was formed in 2013 as a spin-out of iPierian.
Company Details
- Address
- South San Francisco, Ca
- Phone
- (650) 872-4700
- in****@****rth.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- truenorthrx.com
- HQ
- South San Francisco, CA
True North Therapeutics Questions
True North Therapeutics's helpline number is (650) 872-4700
True North Therapeutics's website is truenorthrx.com
True North Therapeutics's LinkedIn profile is https://www.linkedin.com/company/true-north-therapeutics
True North Therapeutics's industry is
Biotechnology Research
True North Therapeutics's top competitors are
Rayonex Biomedical Gmbh,
Mercaptor, Inc.,
Star Therapeutics,
Electra Therapeutics,
Goal Therapeutics,
B4x Therapeutics,
Vega Therapeutics,
Triphos Therapeutics, Inc.,
Encepheal Therapeutics,
Bioverativ, A Sanofi Company.
True North Therapeutics's support email address is info@truenorth.com
True North Therapeutics's categories are Biotechnology Research
